ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Review Article



Neonatal screening for congenital adrenal hyperplasia

Ediz Yeşilkaya, Erkan Sarı.



Abstract
Download PDF Post

Congenital adrenal hyperplasia (CAH) is an autosomal recessive disease causing gender differentation disorder. 21-Hydroxylase deficiency comprises more than 90% of patients and leads to cortisol deficiency. Cortisol deficiency causes life threatining adrenal failure. The diagnosis could be missed and the disease may cause to death especially in male neonate and girls with virilised severely.
After the CAH diagnosis, the management of disease is possible both medical and surgical. Therefore neonatal CAH screening program is performed in many developed countries. Both male and female infant death can be prevented as well as early medical/surgical intervention correct the problems without grow-up. Europe and American Societies of Pediatric Endocrinology recommend the neonatal CAH screening. Because of all these reason neonatal CAH screening is important and necessary in our country that has high prevalence of consanguineous marriage.

Key words: Newborn, Screening, Congenital Adrenal Hyperplasia

Article Language: Turkish English







Bibliomed Article Statistics

10
22
39
25
17
19
21
29
31
33
19
23
R
E
A
D
S

33

28

24

26

30

29

44

40

53

31

17

6
D
O
W
N
L
O
A
D
S
050607080910111201020304
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.